{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:25:33Z","timestamp":1778772333408,"version":"3.51.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T00:00:00Z","timestamp":1593907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T00:00:00Z","timestamp":1593907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10067-020-05257-3","type":"journal-article","created":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T00:02:42Z","timestamp":1593907362000},"page":"491-499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cutaneous lupus erythematosus and cardiovascular disease: current knowledge and insights into pathogenesis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2152-3567","authenticated-orcid":false,"given":"Lisa N.","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4170-7681","authenticated-orcid":false,"given":"Vinod E.","family":"Nambudiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,5]]},"reference":[{"issue":"2","key":"5257_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/096120339700600204","volume":"6","author":"B Tebbe","year":"1997","unstructured":"Tebbe B, Orfanos CE (1997) Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 6(2):96\u2013104. https:\/\/doi.org\/10.1177\/096120339700600204","journal-title":"Lupus"},{"issue":"4","key":"5257_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/s0190-9622(81)80261-7","volume":"4","author":"JN Gilliam","year":"1981","unstructured":"Gilliam JN, Sontheimer RD (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4(4):471\u2013475. https:\/\/doi.org\/10.1016\/s0190-9622(81)80261-7","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"5257_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.berh.2013.07.008","volume":"27","author":"LG Okon","year":"2013","unstructured":"Okon LG, Werth VP (2013) Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol 27(3):391\u2013404. https:\/\/doi.org\/10.1016\/j.berh.2013.07.008","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"5257_CR4","first-page":"200","volume":"65","author":"VP Werth","year":"2007","unstructured":"Werth VP (2007) Cutaneous lupus: insights into pathogenesis and disease classification. Bull NYU Hosp Jt Dis 65(3):200\u2013204","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"5","key":"5257_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/BOR.0000000000000308","volume":"28","author":"JN Stannard","year":"2016","unstructured":"Stannard JN, Kahlenberg JM (2016) Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus. Curr Opin Rheumatol 28(5):453\u2013459. https:\/\/doi.org\/10.1097\/BOR.0000000000000308","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"5257_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1600-0625.2007.00556.x","volume":"16","author":"J Wenzel","year":"2007","unstructured":"Wenzel J, T\u00fcting T (2007) Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches. Exp Dermatol 16(5):454\u2013463. https:\/\/doi.org\/10.1111\/j.1600-0625.2007.00556.x","journal-title":"Exp Dermatol"},{"issue":"11","key":"5257_CR7","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1002\/art.21398","volume":"52","author":"K Popovic","year":"2005","unstructured":"Popovic K, Ek M, Espinosa A, Padyukov L, Harris HE, Wahren-Herlenius M, Nyberg F (2005) Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 52(11):3639\u20133645. https:\/\/doi.org\/10.1002\/art.21398","journal-title":"Arthritis Rheum"},{"issue":"6","key":"5257_CR8","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1002\/art.22699","volume":"56","author":"B Franz","year":"2007","unstructured":"Franz B, Fritzsching B, Riehl A, Oberle N, Klemke CD, Sykora J, Quick S, Stumpf C, Hartmann M, Enk A, Ruzicka T, Krammer PH, Suri-Payer E, Kuhn A (2007) Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum 56(6):1910\u20131920. https:\/\/doi.org\/10.1002\/art.22699","journal-title":"Arthritis Rheum"},{"issue":"6","key":"5257_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/acr.23018","volume":"69","author":"JA Avi\u00f1a-Zubieta","year":"2017","unstructured":"Avi\u00f1a-Zubieta JA, To F, Vostretsova K, De Vera M, Sayre EC, Esdaile JM (2017) Risk of myocardial infarction and stroke in newly diagnosed systemic lupus Erythematosus: a general population-based study. Arthritis Care Res (Hoboken) 69(6):849\u2013856. https:\/\/doi.org\/10.1002\/acr.23018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"5257_CR10","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/art.24537","volume":"61","author":"AE Hak","year":"2009","unstructured":"Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH (2009) Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum 61(10):1396\u20131402. https:\/\/doi.org\/10.1002\/art.24537","journal-title":"Arthritis Rheum"},{"issue":"2","key":"5257_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000062","volume":"2","author":"EJ Armstrong","year":"2013","unstructured":"Armstrong EJ, Harskamp CT, Armstrong AW (2013) Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc 2(2):e000062. https:\/\/doi.org\/10.1161\/JAHA.113.000062","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"5257_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","volume":"74","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Yu Y, Haynes K, Love TJ, Maliha S, Jiang Y, Troxel AB, Hennessy S, Kimmel SE, Margolis DJ, Choi H, Mehta NN, Gelfand JM (2015) Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 74(2):326\u2013332. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205675","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"5257_CR13","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 71(9):1524\u20131529. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200726","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"5257_CR14","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han C, Robinson DW, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33(11):2167\u20132172","journal-title":"J Rheumatol"},{"issue":"16","key":"5257_CR15","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685\u20131695. https:\/\/doi.org\/10.1056\/NEJMra043430","journal-title":"N Engl J Med"},{"issue":"21 Suppl 1","key":"5257_CR16","doi-asserted-by":"publisher","first-page":"II2","DOI":"10.1161\/01.CIR.0000129535.04194.38","volume":"109","author":"JT Willerson","year":"2004","unstructured":"Willerson JT, Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109(21 Suppl 1):II2\u2013I10. https:\/\/doi.org\/10.1161\/01.CIR.0000129535.04194.38","journal-title":"Circulation"},{"issue":"1","key":"5257_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/rheumatology\/kem202","volume":"47","author":"SI van Leuven","year":"2008","unstructured":"van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ES, Tak PP (2008) Systemic inflammation as a risk factor for atherothrombosis. Rheumatology (Oxford) 47(1):3\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/kem202","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5257_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0961203316651739","volume":"26","author":"JH Hesselvig","year":"2017","unstructured":"Hesselvig JH, Ahlehoff O, Dreyer L, Gislason G, Kofoed K (2017) Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. Lupus 26(1):48\u201353. https:\/\/doi.org\/10.1177\/0961203316651739","journal-title":"Lupus"},{"issue":"11","key":"5257_CR19","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/acr.22892","volume":"68","author":"AG Singh","year":"2016","unstructured":"Singh AG, Crowson CS, Singh S, Denis M, Davis P, Maradit-Kremers H, Matteson EL, Chowdhary VR (2016) Risk of cerebrovascular accidents and ischemic heart disease in cutaneous lupus Erythematosus: a population-based cohort study. Arthritis Care Res (Hoboken) 68(11):1664\u20131670. https:\/\/doi.org\/10.1002\/acr.22892","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"5257_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033442","volume":"7","author":"B Z\u00f6ller","year":"2012","unstructured":"Z\u00f6ller B, Li X, Sundquist J, Sundquist K (2012) Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One 7(3):e33442. https:\/\/doi.org\/10.1371\/journal.pone.0033442","journal-title":"PLoS One"},{"key":"5257_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2377-12-41","volume":"12","author":"B Z\u00f6ller","year":"2012","unstructured":"Z\u00f6ller B, Li X, Sundquist J, Sundquist K (2012) Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol 12:41. https:\/\/doi.org\/10.1186\/1471-2377-12-41","journal-title":"BMC Neurol"},{"issue":"13","key":"5257_CR22","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1177\/0961203317716306","volume":"26","author":"O Ahlehoff","year":"2017","unstructured":"Ahlehoff O, Wu JJ, Rauns\u00f8 J, Kristensen SL, Khalid U, Kofoed K, Gislason G (2017) Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: a Danish nationwide cohort study. Lupus 26(13):1435\u20131439. https:\/\/doi.org\/10.1177\/0961203317716306","journal-title":"Lupus"},{"issue":"4","key":"5257_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/ajg.2011.53","volume":"106","author":"SK Murthy","year":"2011","unstructured":"Murthy SK, Nguyen GC (2011) Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol 106(4):713\u2013718. https:\/\/doi.org\/10.1038\/ajg.2011.53","journal-title":"Am J Gastroenterol"},{"issue":"9715","key":"5257_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","volume":"375","author":"MJ Grainge","year":"2010","unstructured":"Grainge MJ, West J, Card TR (2010) Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375(9715):657\u2013663. https:\/\/doi.org\/10.1016\/S0140-6736(09)61963-2","journal-title":"Lancet"},{"issue":"6917","key":"5257_CR25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868\u2013874. https:\/\/doi.org\/10.1038\/nature01323","journal-title":"Nature"},{"issue":"7","key":"5257_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nri1882","volume":"6","author":"GK Hansson","year":"2006","unstructured":"Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6(7):508\u2013519. https:\/\/doi.org\/10.1038\/nri1882","journal-title":"Nat Rev Immunol"},{"issue":"6890","key":"5257_CR27","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nature00804","volume":"417","author":"K Sk\u00e5l\u00e9n","year":"2002","unstructured":"Sk\u00e5l\u00e9n K, Gustafsson M, Rydberg EK, Hult\u00e9n LM, Wiklund O, Innerarity TL, Bor\u00e9n J (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417(6890):750\u2013754. https:\/\/doi.org\/10.1038\/nature00804","journal-title":"Nature"},{"issue":"5","key":"5257_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00041433-200310000-00002","volume":"14","author":"N Leitinger","year":"2003","unstructured":"Leitinger N (2003) Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol 14(5):421\u2013430. https:\/\/doi.org\/10.1097\/00041433-200310000-00002","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"5257_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0021-9150(99)00011-8","volume":"145","author":"J Frosteg\u00e5rd","year":"1999","unstructured":"Frosteg\u00e5rd J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK (1999) Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145(1):33\u201343. https:\/\/doi.org\/10.1016\/s0021-9150(99)00011-8","journal-title":"Atherosclerosis"},{"issue":"9","key":"5257_CR30","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1172\/JCI118650","volume":"97","author":"K Uyemura","year":"1996","unstructured":"Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, Gately MK, Warrier RR, Pham N, Fogelman AM, Modlin RL (1996) Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 97(9):2130\u20132138. https:\/\/doi.org\/10.1172\/JCI118650","journal-title":"J Clin Invest"},{"issue":"12","key":"5257_CR31","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1161\/hq1201.100220","volume":"21","author":"GK Hansson","year":"2001","unstructured":"Hansson GK (2001) Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21(12):1876\u20131890. https:\/\/doi.org\/10.1161\/hq1201.100220","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5257_CR32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","volume":"21","author":"SJ Szabo","year":"2003","unstructured":"Szabo SJ, Sullivan BM, Peng SL, Glimcher LH (2003) Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 21:713\u2013758. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.140942","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"5257_CR33","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ijcard.2014.07.079","volume":"176","author":"N Trieu","year":"2014","unstructured":"Trieu N, Eslick GD (2014) Alopecia and its association with coronary heart disease and cardiovascular risk factors: a meta-analysis. Int J Cardiol 176(3):687\u2013695. https:\/\/doi.org\/10.1016\/j.ijcard.2014.07.079","journal-title":"Int J Cardiol"},{"issue":"10","key":"5257_CR34","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/all.12685","volume":"70","author":"JI Silverberg","year":"2015","unstructured":"Silverberg JI (2015) Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy 70(10):1300\u20131308. https:\/\/doi.org\/10.1111\/all.12685","journal-title":"Allergy"},{"issue":"1","key":"5257_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/jid.2013.269","volume":"134","author":"A Jabbari","year":"2014","unstructured":"Jabbari A, Su\u00e1rez-Fari\u00f1as M, Fuentes-Duculan J, Gonzalez J, Cueto I, Franks AG, Krueger JG (2014) Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis. J Invest Dermatol 134(1):87\u201395. https:\/\/doi.org\/10.1038\/jid.2013.269","journal-title":"J Invest Dermatol"},{"issue":"2","key":"5257_CR36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0008-8749(90)90052-s","volume":"128","author":"GR Klimpel","year":"1990","unstructured":"Klimpel GR, Infante AJ, Patterson J, Hess CB, Asuncion M (1990) Virus-induced interferon alpha\/beta (IFN-alpha\/beta) production by T cells and by Th1 and Th2 helper T cell clones: a study of the immunoregulatory actions of IFN-gamma versus IFN-alpha\/beta on functions of different T cell populations. Cell Immunol 128(2):603\u2013618. https:\/\/doi.org\/10.1016\/0008-8749(90)90052-s","journal-title":"Cell Immunol"},{"issue":"4","key":"5257_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/path.1721","volume":"205","author":"J Wenzel","year":"2005","unstructured":"Wenzel J, W\u00f6renk\u00e4mper E, Freutel S, Henze S, Haller O, Bieber T, T\u00fcting T (2005) Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol 205(4):435\u2013442. https:\/\/doi.org\/10.1002\/path.1721","journal-title":"J Pathol"},{"issue":"2","key":"5257_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ygeno.2014.11.004","volume":"105","author":"R Dey-Rao","year":"2015","unstructured":"Dey-Rao R, Sinha AA (2015) Genome-wide transcriptional profiling of chronic cutaneous lupus erythematosus (CCLE) peripheral blood identifies systemic alterations relevant to the skin manifestation. Genomics 105(2):90\u2013100. https:\/\/doi.org\/10.1016\/j.ygeno.2014.11.004","journal-title":"Genomics"},{"issue":"2","key":"5257_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaad.2013.03.015","volume":"69","author":"K Foering","year":"2013","unstructured":"Foering K, Chang AY, Piette EW, Cucchiara A, Okawa J, Werth VP (2013) Characterization of clinical photosensitivity in cutaneous lupus erythematosus. J Am Acad Dermatol 69(2):205\u2013213. https:\/\/doi.org\/10.1016\/j.jaad.2013.03.015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"5257_CR40","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/jid.2008.332","volume":"129","author":"MM Bashir","year":"2009","unstructured":"Bashir MM, Sharma MR, Werth VP (2009) UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription. J Invest Dermatol 129(4):994\u20131001. https:\/\/doi.org\/10.1038\/jid.2008.332","journal-title":"J Invest Dermatol"},{"issue":"4","key":"5257_CR41","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/ard.2005.039362","volume":"65","author":"S Zampieri","year":"2006","unstructured":"Zampieri S, Alaibac M, Iaccarino L, Rondinone R, Ghirardello A, Sarzi-Puttini P, Peserico A, Doria A (2006) Tumour necrosis factor alpha is expressed in refractory skin lesions from patients with subacute cutaneous lupus erythematosus. Ann Rheum Dis 65(4):545\u2013548. https:\/\/doi.org\/10.1136\/ard.2005.039362","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5257_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pharmthera.2010.05.002","volume":"127","author":"P Kleinbongard","year":"2010","unstructured":"Kleinbongard P, Heusch G, Schulz R (2010) TNFalpha in atherosclerosis, myocardial ischemia\/reperfusion and heart failure. Pharmacol Ther 127(3):295\u2013314. https:\/\/doi.org\/10.1016\/j.pharmthera.2010.05.002","journal-title":"Pharmacol Ther"},{"key":"5257_CR43","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.3389\/fimmu.2019.03096","volume":"10","author":"E von Stebut","year":"2019","unstructured":"von Stebut E, Boehncke WH, Ghoreschi K, Gori T, Kaya Z, Thaci D, Sch\u00e4ffler A (2019) IL-17A in psoriasis and beyond: cardiovascular and metabolic implications. Front Immunol 10:3096. https:\/\/doi.org\/10.3389\/fimmu.2019.03096","journal-title":"Front Immunol"},{"issue":"2","key":"5257_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cyto.2013.03.013","volume":"62","author":"JB Golden","year":"2013","unstructured":"Golden JB, McCormick TS, Ward NL (2013) IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities. Cytokine 62(2):195\u2013201. https:\/\/doi.org\/10.1016\/j.cyto.2013.03.013","journal-title":"Cytokine"},{"issue":"3","key":"5257_CR45","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejim.2010.03.004","volume":"21","author":"C Tanasescu","year":"2010","unstructured":"Tanasescu C, Balanescu E, Balanescu P, Olteanu R, Badea C, Grancea C, Vagu C, Bleotu C, Ardeleanu C, Georgescu A (2010) IL-17 in cutaneous lupus erythematosus. Eur J Intern Med 21(3):202\u2013207. https:\/\/doi.org\/10.1016\/j.ejim.2010.03.004","journal-title":"Eur J Intern Med"},{"issue":"6","key":"5257_CR46","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","volume":"164","author":"CM Gr\u00f6nhagen","year":"2011","unstructured":"Gr\u00f6nhagen CM, Fored CM, Granath F, Nyberg F (2011) Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol 164(6):1335\u20131341. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10272.x","journal-title":"Br J Dermatol"},{"issue":"2 Pt 1","key":"5257_CR47","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/s0190-9622(85)80036-0","volume":"12","author":"JP Callen","year":"1985","unstructured":"Callen JP (1985) Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients. J Am Acad Dermatol 12(2 Pt 1):278\u2013288. https:\/\/doi.org\/10.1016\/s0190-9622(85)80036-0","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"5257_CR48","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","volume":"145","author":"S Manzi","year":"1997","unstructured":"Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, D'Agostino RB, Kuller LH (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 145(5):408\u2013415. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009122","journal-title":"Am J Epidemiol"},{"issue":"4","key":"5257_CR49","first-page":"713","volume":"31","author":"L Bj\u00f6rn\u00e5dal","year":"2004","unstructured":"Bj\u00f6rn\u00e5dal L, Yin L, Granath F, Klareskog L, Ekbom A (2004) Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. J Rheumatol 31(4):713\u2013719","journal-title":"J Rheumatol"},{"issue":"4","key":"5257_CR50","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","volume":"108","author":"N Sattar","year":"2003","unstructured":"Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland coronary prevention study. Circulation 108(4):414\u2013419. https:\/\/doi.org\/10.1161\/01.CIR.0000080897.52664.94","journal-title":"Circulation"},{"key":"5257_CR51","doi-asserted-by":"publisher","unstructured":"Alexander CM, Landsman PB, Teutsch SM, Haffner SM, III) TNHaNESN, (NCEP) NCEP (2003) NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (5):1210\u20131214. doi:https:\/\/doi.org\/10.2337\/diabetes.52.5.1210","DOI":"10.2337\/diabetes.52.5.1210"},{"issue":"10","key":"5257_CR52","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","volume":"110","author":"S Malik","year":"2004","unstructured":"Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110(10):1245\u20131250. https:\/\/doi.org\/10.1161\/01.CIR.0000140677.20606.0E","journal-title":"Circulation"},{"key":"5257_CR53","doi-asserted-by":"publisher","first-page":"3972706","DOI":"10.1155\/2017\/3972706","volume":"2017","author":"S Akarsu","year":"2017","unstructured":"Akarsu S, Ozbagcivan O, Semiz F, Aktan S (2017) High prevalence of metabolic syndrome in patients with discoid lupus Erythematosus: a cross-sectional, case-control study. J Immunol Res 2017:3972706\u20133972708. https:\/\/doi.org\/10.1155\/2017\/3972706","journal-title":"J Immunol Res"},{"key":"5257_CR54","doi-asserted-by":"publisher","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Prevention IDFTFoEa, Hational Heart Ln, and Blood Institute, Association AH, Federation WH, Society IA, Obesity IAftSo (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation 120 (16):1640\u20131645. doi:https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192644","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"issue":"9943","key":"5257_CR55","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","volume":"384","author":"DJ Rader","year":"2014","unstructured":"Rader DJ, Hovingh GK (2014) HDL and cardiovascular disease. Lancet 384(9943):618\u2013625. https:\/\/doi.org\/10.1016\/S0140-6736(14)61217-4","journal-title":"Lancet"},{"issue":"7","key":"5257_CR56","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrcardio.2017.31","volume":"14","author":"\u017d Reiner","year":"2017","unstructured":"Reiner \u017d (2017) Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol 14(7):401\u2013411. https:\/\/doi.org\/10.1038\/nrcardio.2017.31","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"5257_CR57","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.clinbiochem.2004.10.006","volume":"38","author":"I Lagogianni","year":"2005","unstructured":"Lagogianni I, Papapanagiotou A, Piperi C, Kalofoutis C, Troupis G, Zachari A, Kalofoutis A (2005) Evidence of reduced plasma HDL subfractions in patients with cutaneous discoid lupus erythematosus. Clin Biochem 38(3):286\u2013290. https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.10.006","journal-title":"Clin Biochem"},{"issue":"10","key":"5257_CR58","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","volume":"43","author":"JA Ambrose","year":"2004","unstructured":"Ambrose JA, Barua RS (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43(10):1731\u20131737. https:\/\/doi.org\/10.1016\/j.jacc.2003.12.047","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"5257_CR59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/euhj.1998.1194","volume":"20","author":"JF Price","year":"1999","unstructured":"Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG (1999) Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh artery study. Eur Heart J 20(5):344\u2013353. https:\/\/doi.org\/10.1053\/euhj.1998.1194","journal-title":"Eur Heart J"},{"issue":"2","key":"5257_CR60","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000086440","volume":"211","author":"HA Miot","year":"2005","unstructured":"Miot HA, Bartoli Miot LD, Haddad GR (2005) Association between discoid lupus erythematosus and cigarette smoking. Dermatology 211(2):118\u2013122. https:\/\/doi.org\/10.1159\/000086440","journal-title":"Dermatology"},{"issue":"7","key":"5257_CR61","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1177\/0961203314559630","volume":"24","author":"BC B\u00f6ckle","year":"2015","unstructured":"B\u00f6ckle BC, Sepp NT (2015) Smoking is highly associated with discoid lupus erythematosus and lupus erythematosus tumidus: analysis of 405 patients. Lupus 24(7):669\u2013674. https:\/\/doi.org\/10.1177\/0961203314559630","journal-title":"Lupus"},{"issue":"4","key":"5257_CR62","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jaad.2014.12.025","volume":"72","author":"F Chasset","year":"2015","unstructured":"Chasset F, Franc\u00e8s C, Barete S, Amoura Z, Arnaud L (2015) Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature. J Am Acad Dermatol 72(4):634\u2013639. https:\/\/doi.org\/10.1016\/j.jaad.2014.12.025","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"5257_CR63","first-page":"231","volume":"63","author":"H Gallego","year":"1999","unstructured":"Gallego H, Crutchfield CE, Lewis EJ, Gallego HJ (1999) Report of an association between discoid lupus erythematosus and smoking. Cutis 63(4):231\u2013234","journal-title":"Cutis"},{"issue":"5","key":"5257_CR64","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jaad.2010.02.008","volume":"64","author":"R Klein","year":"2011","unstructured":"Klein R, Moghadam-Kia S, Taylor L, Coley C, Okawa J, LoMonico J, Chren MM, Werth VP (2011) Quality of life in cutaneous lupus erythematosus. J Am Acad Dermatol 64(5):849\u2013858. https:\/\/doi.org\/10.1016\/j.jaad.2010.02.008","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"5257_CR65","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/bjd.14392","volume":"174","author":"Jalenques I, Rondepierre F, Massoubre C, Haffen E, Grand JP, Labeille B, Perrot JL, Aubin F, Skowron F, Mulliez A, D'Incan M, Group L","year":"2016","unstructured":"Jalenques I, Rondepierre F, Massoubre C, Haffen E, Grand JP, Labeille B, Perrot JL, Aubin F, Skowron F, Mulliez A, D'Incan M, Group L (2016) High prevalence of psychiatric disorders in patients with skin-restricted lupus: a case-control study. Br J Dermatol 174(5):1051\u20131060. https:\/\/doi.org\/10.1111\/bjd.14392","journal-title":"Br J Dermatol"},{"issue":"16","key":"5257_CR66","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1161\/01.cir.99.16.2192","volume":"99","author":"A Rozanski","year":"1999","unstructured":"Rozanski A, Blumenthal JA, Kaplan J (1999) Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99(16):2192\u20132217. https:\/\/doi.org\/10.1161\/01.cir.99.16.2192","journal-title":"Circulation"},{"issue":"5","key":"5257_CR67","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jacc.2004.12.005","volume":"45","author":"A Rozanski","year":"2005","unstructured":"Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L (2005) The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 45(5):637\u2013651. https:\/\/doi.org\/10.1016\/j.jacc.2004.12.005","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"5257_CR68","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1161\/hc0902.104707","volume":"105","author":"F Lesperance","year":"2002","unstructured":"Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG (2002) Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105(9):1049\u20131053. https:\/\/doi.org\/10.1161\/hc0902.104707","journal-title":"Circulation"},{"issue":"1","key":"5257_CR69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/acr.22992","volume":"69","author":"A Jorge","year":"2017","unstructured":"Jorge A, Lertratanakul A, Lee J, Pearce W, McPherson D, Thompson T, Barinas-Mitchell E, Ramsey-Goldman R (2017) Depression and progression of subclinical cardiovascular disease in systemic lupus Erythematosus. Arthritis Care Res (Hoboken) 69(1):5\u201311. https:\/\/doi.org\/10.1002\/acr.22992","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"5257_CR70","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/ced.12884","volume":"41","author":"CM Gr\u00f6nhagen","year":"2016","unstructured":"Gr\u00f6nhagen CM, Tang MB, Tan VW, Tan KW, Lim YL (2016) Vitamin D levels in 87 Asian patients with cutaneous lupus erythematosus: a case-control study. Clin Exp Dermatol 41(7):723\u2013729. https:\/\/doi.org\/10.1111\/ced.12884","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"5257_CR71","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1365-2133.2010.09948.x","volume":"163","author":"G Heine","year":"2010","unstructured":"Heine G, Lahl A, M\u00fcller C, Worm M (2010) Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year. Br J Dermatol 163(4):863\u2013865. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09948.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"5257_CR72","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2008.10.033","volume":"205","author":"J Kendrick","year":"2009","unstructured":"Kendrick J, Targher G, Smits G, Chonchol M (2009) 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the third National Health and nutrition examination survey. Atherosclerosis 205(1):255\u2013260. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.10.033","journal-title":"Atherosclerosis"},{"issue":"11","key":"5257_CR73","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.amjcard.2008.06.067","volume":"102","author":"DH Kim","year":"2008","unstructured":"Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ (2008) Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and nutrition examination survey 2001 to 2004). Am J Cardiol 102(11):1540\u20131544. https:\/\/doi.org\/10.1016\/j.amjcard.2008.06.067","journal-title":"Am J Cardiol"},{"issue":"11","key":"5257_CR74","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","volume":"167","author":"D Martins","year":"2007","unstructured":"Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the third National Health and nutrition examination survey. Arch Intern Med 167(11):1159\u20131165. https:\/\/doi.org\/10.1001\/archinte.167.11.1159","journal-title":"Arch Intern Med"},{"issue":"8","key":"5257_CR75","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1002\/acr.22291","volume":"66","author":"A Lertratanakul","year":"2014","unstructured":"Lertratanakul A, Wu P, Dyer A, Urowitz M, Gladman D, Fortin P, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Merrill J, Wallace DJ, Ginzler E, Khamashta M, Bruce I, Nived O, Sturfelt G, Steinsson K, Manzi S, Dooley MA, Kalunian K, Petri M, Aranow C, Font J, van Vollenhoven R, Stoll T, Ramsey-Goldman R (2014) 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care Res (Hoboken) 66(8):1167\u20131176. https:\/\/doi.org\/10.1002\/acr.22291","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"5257_CR76","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/art.24785","volume":"61","author":"PW Wu","year":"2009","unstructured":"Wu PW, Rhew EY, Dyer AR, Dunlop DD, Langman CB, Price H, Sutton-Tyrrell K, McPherson DD, Edmundowicz D, Kondos GT, Ramsey-Goldman R (2009) 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 61(10):1387\u20131395. https:\/\/doi.org\/10.1002\/art.24785","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5257_CR77","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/rheumatology\/ker352","volume":"51","author":"JA Reynolds","year":"2012","unstructured":"Reynolds JA, Haque S, Berry JL, Pemberton P, Teh LS, Ho P, Gorodkin R, Bruce IN (2012) 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford) 51(3):544\u2013551. https:\/\/doi.org\/10.1093\/rheumatology\/ker352","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"5257_CR78","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/MAJ.0b013e31823fa7d9","volume":"344","author":"RL Ravenell","year":"2012","unstructured":"Ravenell RL, Kamen DL, Spence JD, Hollis BW, Fleury TJ, Janech MG, Almeida JS, Shaftman SR, Oates JC (2012) Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am J Med Sci 344(4):268\u2013273. https:\/\/doi.org\/10.1097\/MAJ.0b013e31823fa7d9","journal-title":"Am J Med Sci"},{"issue":"4","key":"5257_CR79","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11926-011-0180-z","volume":"13","author":"AY Chang","year":"2011","unstructured":"Chang AY, Werth VP (2011) Treatment of cutaneous lupus. Curr Rheumatol Rep 13(4):300\u2013307. https:\/\/doi.org\/10.1007\/s11926-011-0180-z","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"5257_CR80","first-page":"714","volume":"145","author":"TK Wu","year":"1977","unstructured":"Wu TK, Tsapogas MJ, Jordan FR (1977) Prophylaxis of deep venous thrombosis by hydroxychloroquine sulfate and heparin. Surg Gynecol Obstet 145(5):714\u2013718","journal-title":"Surg Gynecol Obstet"},{"issue":"5923","key":"5257_CR81","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/bmj.3.5923.94","volume":"3","author":"AE Carter","year":"1974","unstructured":"Carter AE, Eban R (1974) Prevention of postoperative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate. Br Med J 3(5923):94\u201395. https:\/\/doi.org\/10.1136\/bmj.3.5923.94","journal-title":"Br Med J"},{"issue":"2","key":"5257_CR82","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/1074248414546324","volume":"20","author":"S Achuthan","year":"2015","unstructured":"Achuthan S, Ahluwalia J, Shafiq N, Bhalla A, Pareek A, Chandurkar N, Malhotra S (2015) Hydroxychloroquine's efficacy as an antiplatelet agent study in healthy volunteers: a proof of concept study. J Cardiovasc Pharmacol Ther 20(2):174\u2013180. https:\/\/doi.org\/10.1177\/1074248414546324","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"5257_CR83","doi-asserted-by":"publisher","unstructured":"Sharma TS, Wasko MC, Tang X, Vedamurthy D, Yan X, Cote J, Bili A (2016) Hydroxychloroquine use is associated with decreased incident cardiovascular events in rheumatoid arthritis patients. J Am Heart Assoc 5(1). https:\/\/doi.org\/10.1161\/JAHA.115.002867","DOI":"10.1161\/JAHA.115.002867"},{"issue":"7","key":"5257_CR84","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3899\/jrheum.161351","volume":"44","author":"S Fasano","year":"2017","unstructured":"Fasano S, Pierro L, Pantano I, Iudici M, Valentini G (2017) Longterm Hydroxychloroquine therapy and low-dose aspirin may have an additive effectiveness in the primary prevention of cardiovascular events in patients with systemic lupus Erythematosus. J Rheumatol 44(7):1032\u20131038. https:\/\/doi.org\/10.3899\/jrheum.161351","journal-title":"J Rheumatol"},{"issue":"4","key":"5257_CR85","first-page":"505","volume":"16","author":"DE Sholter","year":"2000","unstructured":"Sholter DE, Armstrong PW (2000) Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol 16(4):505\u2013511","journal-title":"Can J Cardiol"},{"issue":"3","key":"5257_CR86","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.det.2010.03.003","volume":"28","author":"M Chen","year":"2010","unstructured":"Chen M, Doherty SD, Hsu S (2010) Innovative uses of thalidomide. Dermatol Clin 28(3):577\u2013586. https:\/\/doi.org\/10.1016\/j.det.2010.03.003","journal-title":"Dermatol Clin"},{"issue":"8","key":"5257_CR87","first-page":"765","volume":"8","author":"SG Fabi","year":"2009","unstructured":"Fabi SG, Hill C, Witherspoon JN, Boone SL, West DP (2009) Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature. J Drugs Dermatol 8(8):765\u2013769","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"5257_CR88","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/archdermatol.2009.21","volume":"145","author":"O Durosaro","year":"2009","unstructured":"Durosaro O, Davis MD, Reed KB, Rohlinger AL (2009) Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study. Arch Dermatol 145(3):249\u2013253. https:\/\/doi.org\/10.1001\/archdermatol.2009.21","journal-title":"Arch Dermatol"},{"key":"5257_CR89","doi-asserted-by":"publisher","unstructured":"Hu SC, Lan CE (2017) Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment. Int J Mol Sci 18(10). https:\/\/doi.org\/10.3390\/ijms18102211","DOI":"10.3390\/ijms18102211"},{"issue":"2","key":"5257_CR90","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40265-013-0173-5","volume":"74","author":"S Churton","year":"2014","unstructured":"Churton S, Brown L, Shin TM, Korman NJ (2014) Does treatment of psoriasis reduce the risk of cardiovascular disease? Drugs 74(2):169\u2013182. https:\/\/doi.org\/10.1007\/s40265-013-0173-5","journal-title":"Drugs"},{"issue":"2","key":"5257_CR91","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12016-016-8560-9","volume":"51","author":"ZS Yang","year":"2016","unstructured":"Yang ZS, Lin NN, Li L, Li Y (2016) The effect of TNF inhibitors on cardiovascular events in psoriasis and psoriatic arthritis: an updated meta-analysis. Clin Rev Allergy Immunol 51(2):240\u2013247. https:\/\/doi.org\/10.1007\/s12016-016-8560-9","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"5257_CR92","first-page":"1213","volume":"32","author":"LT Jacobsson","year":"2005","unstructured":"Jacobsson LT, Turesson C, G\u00fclfe A, Kapetanovic MC, Petersson IF, Saxne T, Geborek P (2005) Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 32(7):1213\u20131218","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05257-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05257-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05257-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T23:30:42Z","timestamp":1625441442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05257-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,5]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["5257"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05257-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,5]]},"assertion":[{"value":"8 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}